There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Concerns regarding the use of direct oral anticoagulants (DOACs: apixaban, dabigatran,
edoxaban, rivaroxaban) in the elderly persist owing to the lack of randomised controlled
trials targeting this age group.